MetaADEDB 2.0 @ LMMD
Ergoloid Mesylates
(UOOWRCRLTSXSAV-GSZJWLEYSA-N)
Structure
SMILES
CS(=O)(=O)O.O=C([C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)N[C@@]1(O[C@@]2(N(C1=O)[C@@H](C(C)C)C(=O)N1[C@H]2CCC1)O)C(C)C
Molecular Formula:
C32H45N5O8S
Molecular Weight:
659.793
Log P:
2.9199
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
4
TPSA:
180.96
CAS Number(s):
14271-04-6; 29261-94-7
Synonym(s)
1.
Ergoloid Mesylates
2.
Co-Dergocrine Mesylate
3.
Dihydroergotoxine Mesylate
4.
Circanol
5.
Co-Dergine Mesylate
6.
Co-Dergocrine Mesilate
7.
Dihydroergotoxine Methanesulfonate
8.
Dihydroergotoxine Monomethanesulfonate
9.
Ergodesit
10.
Ergoloid Mesylate
11.
Ergotoxin, Dihydro-, Monomethasulfonate
12.
Hydergine
13.
Redergam
14.
Redergin
15.
Redergine
16.
Co Dergine Mesylate
17.
Co Dergocrine Mesilate
18.
Co Dergocrine Mesylate
19.
Methanesulfonate, Dihydroergotoxine
20.
Monomethanesulfonate, Dihydroergotoxine
External Link(s)
MeSHD004877
PubChem Compound168870
ChEBI34502
CHEMBLCHEMBL2356227
KEGGcpd:C14053
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 9
Canada Vigilance: 1		Canada Vigilance
US FAERS
2Cerebrovascular accidentFAERS: 7US FAERS
3Memory impairmentFAERS: 6US FAERS
4Diabetes MellitusFAERS: 4US FAERS
5Feeling abnormalFAERS: 3US FAERS
6HypokinesiaFAERS: 3US FAERS
7TremorFAERS: 3US FAERS
8AbasiaFAERS: 2US FAERS
9Brain HypoxiaFAERS: 2US FAERS
10Drug dispensing errorFAERS: 2US FAERS
11Gastrointestinal carcinomaFAERS: 2US FAERS
12Head discomfortFAERS: 2US FAERS
13LabyrinthitisFAERS: 2US FAERS
14Myocardial InfarctionFAERS: 2US FAERS
15PneumoniaFAERS: 2US FAERS
16Urinary tract infectionFAERS: 2US FAERS
17Weight decreasedFAERS: 2US FAERS
18AgitationFAERS: 1US FAERS
19Altered state of consciousnessFAERS: 1US FAERS
20AmnesiaFAERS: 1US FAERS
21Angina PectorisFAERS: 1US FAERS
22AstheniaFAERS: 1US FAERS
23BedriddenFAERS: 1US FAERS
24BlindnessFAERS: 1US FAERS
25CataractFAERS: 1US FAERS
26Depressed moodFAERS: 1US FAERS
27Disease ProgressionFAERS: 1US FAERS
28Drug DependenceFAERS: 1US FAERS
29Drug ineffectiveFAERS: 1US FAERS
30DysgeusiaFAERS: 1US FAERS
31Emotional disorderFAERS: 1US FAERS
32Expired product administeredFAERS: 1US FAERS
33Feeling ColdFAERS: 1US FAERS
34FractureFAERS: 1US FAERS
35HeadacheFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
36HypophagiaFAERS: 1US FAERS
37HypoxiaFAERS: 1US FAERS
38Incorrect dose administeredFAERS: 1US FAERS
39MalaiseFAERS: 1US FAERS
40MyalgiaFAERS: 1US FAERS
41Panic DisorderFAERS: 1US FAERS
42PresyncopeFAERS: 1US FAERS
43Product quality issueFAERS: 1US FAERS
44PruritusFAERS: 1
Canada Vigilance: 2		Canada Vigilance
US FAERS
45RetchingFAERS: 1US FAERS
46Senile dementiaFAERS: 1US FAERS
47Strangulated herniaFAERS: 1US FAERS
48Suicide attemptFAERS: 1US FAERS
49SwellingFAERS: 1US FAERS
50SyncopeFAERS: 1US FAERS
51Throat irritationFAERS: 1US FAERS
52TinnitusFAERS: 1US FAERS
53Ventricular arrhythmiaFAERS: 1US FAERS
54Visual ImpairmentFAERS: 1US FAERS
55AnxietyCanada Vigilance: 1Canada Vigilance
56ErythemaCanada Vigilance: 1Canada Vigilance
57HyperkinesiaCanada Vigilance: 1Canada Vigilance
58HypersensitivityCanada Vigilance: 1Canada Vigilance
59LethargyCanada Vigilance: 1Canada Vigilance
60NauseaCanada Vigilance: 1Canada Vigilance
61RhinitisCanada Vigilance: 1Canada Vigilance
62VertigoCanada Vigilance: 1Canada Vigilance
63VomitingCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.